Chad Messer – Needham

Needham

A Needham analyst with 5 tracked ratings covering 5 distinct tickers has a 40% success rate on the captured sample, focusing exclusively on one source.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

4 years ago

2021-08-03 00:00:00+00

Track record

Aggregated

40% success rate

Bullish: 5
Hold: 0
Bearish: 0

Aggregated

Not available

Recent ratings

Ticker	Date	Rating	Price target	Source
ESPR	2021-08-03	buy	$114.00	Aggregated
ESPRESPERION THERAPEUTICS INC.	2021-08-03	unknown	$114.00	Aggregated
CELC	2021-07-27	buy	$50.00	Aggregated
CELCCELCUITY INC	2021-07-27	unknown	$50.00	Aggregated
CYTK	2021-07-19	buy	$48.00	Aggregated
CYTKCYTOKINETICS INC	2021-07-19	unknown	$48.00	Aggregated
EXEL	2021-06-28	buy	$30.00	Aggregated
EXELEXELIXIS INC	2021-06-28	unknown	$30.00	Aggregated
RNA	2021-06-17	buy	$50.00	Aggregated
RNAAVIDITY BIOSCIENCES INC	2021-06-17	unknown	$50.00	Aggregated

Tickers covered(10)

Ticker	Ratings	Last rating	Sources
ESPR	2	2021-08-03	Aggregated
ESPRESPERION THERAPEUTICS INC.	1	2021-08-03	Aggregated
CELC	2	2021-07-27	Aggregated
CELCCELCUITY INC	1	2021-07-27	Aggregated
CYTK	2	2021-07-19	Aggregated
CYTKCYTOKINETICS INC	1	2021-07-19	Aggregated
EXEL	2	2021-06-28	Aggregated
EXELEXELIXIS INC	1

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.